期刊文献+

糖皮质激素受体在白血病CYP3A5耐药中的信号转导作用

Signal transduction effect of glucocorticoid receptor in drug resistance of CYP3A5 in leukemia
下载PDF
导出
摘要 目的探讨糖皮质激素受体在白血病CYP3A5耐药中的信号转导作用。方法采用DNA重组技术构建ptracer-hGR重组质粒,并用报告基因检测方法研究糖皮质激素受体对CYP3A5药物代谢酶转录、表达调控中的信号转导作用。结果菌落PCR及测序证实成功构建ptracer-hGR重组质粒。经阿糖胞苷、甲氨蝶呤和长春新碱三种化疗药物加药后共转染ptracer-hGR质粒的实验组荧光素酶相对活性显著高于单纯转染CYP3A5报告基因质粒的对照组,差异具有统计学意义(P=0.0362、0.0034和0.0164);而卡铂和米托蒽醌加药后,荧光素酶相对活性无明显增高趋势。结论阿糖胞苷、甲氨蝶呤和长春新碱三种化疗药物可能通过激活糖皮质激素受体这一信号途径而上调CYP3A5 mRNA的转录。 Objective To investigate the signal transduction effect of glucocorticoid receptor in the drug resistance of CYP3A5 in leukemia. Methods The ptracer-hGR recombinant plasmid was constructed using DNA recombinant technology,and the signal transduction effect of glucocorticoid receptor in the regulation of drugs on the transcription and expression of CYP3A5 was analysed by reporter gene assay. Results Colony PCR and sequencing indicated that the ptracer-hGR recombinant plasmid was constructed successfully.The relative luciferase activity in the test cells co-transfected with ptracer-hGR was remarkably higher than that in the control cells transfected with pGL3-CYP3A5 promotor alone after the cells were subjected to the chemotherapy drugs such as cytosine arabinoside(Ara-C),methotrexate(MTX) and vincristine(VCR)(P=0.036 2,0.003 4 and 0.016 4,respectively).However,the relative luciferase activity had either no or only a slight increase after the cells were subjected to the other chemotherapy drugs such as carboplatin and mitoxantrone. ConclusionAra-C,MTX and VCR may up-regulate the transcription of CYP3A5 mRNA by activation of glucocorticoid receptor.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第8期950-952,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30400183)~~
关键词 CYP3A5基因 糖皮质激素受体 耐药 质粒转染 报告基因 CYP3A5 gene glucocorticoid receptor drug resistance plasmid transfection reporter gene
  • 相关文献

参考文献9

二级参考文献41

  • 1Yu LJ, Matias J, Scudiero DA, et al. P450 enzyme expression patterns in the NCI human tumor cell line panel. Drug Metab Dispos, 2001, 29: 304-312. 被引量:1
  • 2Gellner K, Eiselt R, Hustert E, et al. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmaeogenetics, 2001, 11: 111-121. 被引量:1
  • 3Groninger E, Meeuwsen-de Boar T, Koopmans P, et al. Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia. Pediatr Res, 2002, 52 : 113-118. 被引量:1
  • 4Villikka K, Kivisto KT, Maenpaa H, et al. Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clin Pharmacol Ther, 1999, 66: 589-593. 被引量:1
  • 5Bohme A, Ganser A, Hoelzer D. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL.Ann Hematol, 1995, 71: 311-312. 被引量:1
  • 6Britten CD, Baker SD, Denis LJ, et al. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel. Clin Cancer Res, 2000, 6: 3459-3468. 被引量:1
  • 7Monsarrat B, Chatelut E, Royer I, et al. Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4. Drug Metab Dispos, 1998, 26: 229-233. 被引量:1
  • 8Wrighton SA, Brian WR, Sari MA, et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450ⅢA5 (HLp3). Mol Pharmacol, 1990, 38: 207-213. 被引量:1
  • 9Lin YS, Dowling AL, Quigley SD, et al. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol, 2002, 62: 162-172. 被引量:1
  • 10Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog, 1995, 13: 129-134. 被引量:1

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部